Cognitive impairment in depressive disorders neuropsychological evaluation of memory and behavioural disturbances

Encephale

Volumn 24, Issue 2, 1998, Pages 138-150

  Emilien, G ^a   Penasse, C ^a   Waltregny, A ^a,b  

^a Centre Neurologique du Botanique   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anxiety; Depression; Memory; Neuropsychology

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BISOPROLOL; CARBAMAZEPINE; CITALOPRAM; DEANXIT; DIHYDROERGOTOXINE MESILATE; FLUOXETINE; FLUPENTIXOL; FLURAZEPAM; HERBACEOUS AGENT; LEVOTHYROXINE SODIUM; LORAZEPAM; MELITRACEN; METFORMIN; PAROXETINE; PHENYTOIN; PIROXICAM BETA CYCLODEXTRIN; PROPRANOLOL; RANITIDINE; SULPIRIDE; TRAZODONE; UNCLASSIFIED DRUG; VALERIAN; VALPROIC ACID;

ADOLESCENT; ADRENERGIC SYSTEM; ADULT; AMNESIA; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTELLIGENCE TEST; MALE; NEUROPSYCHOLOGICAL TEST; PERSONALITY TEST;

ADOLESCENT; ADULT; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; RETENTION (PSYCHOLOGY); SOCIAL BEHAVIOR;

EID: 0031780076     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. WEINGARTNER H, COHEN RM, MURPHY DL et al. Cognitive processes in depression. Arch Gen Psychiatry 1981 ; 38 : 42-7.
2. STROMGREN LS. The influence of depression on memory. Acta Psychiatr Scand 1977 ; 56 : 109-28.
3. KOVACS M, AARON T. Maladaptive cognitive structures in depression. Am J Psychiatry 1978 ; 135 : 525-33.
4. WEINGARTNER H, SILBERMAN E. Models of cognitive impairment : cognitive changes in depression. Psychopharmacol Bull 1982 ; 18 : 27-42.
5. BACKMAN L, FORSELL Y. Episodic memory functioning in a community-based sample of old adults with major depression : utilization of cognitive support. J Abnorm Psychol 1994 ; 103 : 361-70.
6. AUSTIN MP, ROSS M, MURRAY C et al. Cognitive function in major depression. J Affect Disord 1992 ; 25 : 21-30.
7. ROY A, JIMERSON D, PICKAR D. Plasma 3-methoxy-4-hydroxy-phenylethyleneglycol in depressive disorders. Am J Psychiatry 1986; 143 : 846-51.
8. MAES M, VANDEWOUDE M, SCHOTTE C et al. Positive relationship between the catecholaminergic turnover and the DST results in depression. Psychol Med 1990 ; 20 : 493-9.
9. CALDECOTT-HAZARD S, MORGAN DG, DE LEON-JONES F et al. Clinical and biochemical aspects of depressive disorders : II. Transmitter/Receptor theories. Synapse 1991 ; 9 : 251-301.
10. SCHATZBERG A, ROTHSCHILD A, LANGLAIS P et al. Psychotic and nonpsychotic depressions. II. Platelet MAO activity, plasma catecholamines, cortisol and specific symptoms. Psychiatry Res 1987; 20: 155-64.
11. STOKES P, MAAS J, DAVIS J et al. Biogenic amine and metabolite levels in depressed patients with high vs normal hypothalamic-pituitary-adrenocortical activity. Am J Psychiatry 1987; 144 : 868-72.
12. CARROLL BJ. Clinical application of neuroendocrine research in depression. In : van Praag MH, Lader MH, Rafaelsen OJ, Sachar EJ, eds. Handbook of biological psychiatry, part III. Brain mechanisms and abnormal behaviour - genetics and neuroendocrinology. New York : Marcel Decker, 1980 : 179-93.
13. HOLSBOER F. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. Eur Arch Psychiatr Neural Sci 1989 ; 238 : 302-22.
14. 1A receptor activation in humans. Eur J Clin Pharmacol 1990 ; 39 : 17-9.
15. VAN DEKAR SD. Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev 1989 ; 13 : 237-46.
16. DEAKIN JFW, PENNELL I, UPADHYAYA AJ et al. A neuroendocrine study of 5-HT function in depression. In : Lerer B, Gershon S, eds. New directions in affective disorders. New York, Berlin : Heidelberg, Springer, 1990 : 5-8.
17. BARDEN N, REUL JMH, HOLSBOER F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system. TINS 1995 ; 18 (1) : 6-11.
18. HEALY D. The structure of psychopharmacological revolutions. Psychiatric Developments 1987 ; 5 : 349-76.
19. SULSER F. Regulation and function of noradrenaline receptor systems in brain. Neuropharmacology 1984 ; 23 : 255-61.
20. HEALY D, O'HALLORAN A, CARNEY PA et al. Peripheral adrenoceptors and serotonin receptors : changes associated with response to treatment with trazodone or amitriptyline. J Affect Disord 1985 ; 9 : 285-96.
21. COWEN PJ, GEANEY DP, SCHACHTER M et al. Desmethy-limipramine treatment in normal subjects : effects on neuroendocrine responses to L-tryptophan and platelet 5HT-related receptors. Arch Gen Psychiatry 1986 ; 43 : 61-7.
22. KERR JS, SHERWOOD N, HINDMARCH I. The comparative psychopharmacology of 5HT reuptake inhibitors. Hum Psychopharmacol 1991 ; 6 : 313-7.
23. O'HANLON JF. Antidepressant therapy and behavioural competence. BJCP 1996 ; 50 (7) : 381-5.
24. MCELROY SL, KECK PE, FRIEDMAN LM. Minimizing and managing antidepressant side effects. J Clin Psychiatry 1995 ; 56 (Suppl. 2) : 49-55.
25. SPENCER PSJ. Review of the pharmacology of existing antidepressants. Br J Clin Pharmacol 1977 ; 4 : 57S-68.
26. LEONARD BE. Antidepressants. Current concepts of mode of action. Encephale 1991 ; XVII : 127-31.
27. EISON MS. Serotonin : a common neurobiologic substrate in anxiety and depression. J Clin Psychopharmacol 1990 ; 10 (Suppl. 3) : 26S-30.
28. LYDIARD RB. Coexisting depression and anxiety : special diagnostic and treatment issues. J Clin Psychiatry 1991 ; 52 (6 suppl.) : 48-54.
29. NEMEROFF CB. Evolutionary trends in the pharmacotherapeutic management of depression. J Clin Psychiatry 1994 ; 55 (12 suppl.) : 315.
30. THOMPSON PJ. Antidepressants and memory : A review. Hum Psychopharmacol 1991 ; 6 : 79-90.
31. SAWLE GV. Imaging the head : functional imaging. J Neurol Psychiatry 1995; 58: 132-44.
32. SNAITH RP. Measurement in Psychiatry. Br J Psychiatry 1991 ; 159 : 78-82.
33. HODGES JR. Cognitive assessment for clinicians. Oxford : Oxford University Press, 1994.
34. CAINE ED. Pseudodementia : Current concepts and future directions. Arch Gen Psychiatry 1981 ; 38 : 1359-64.
35. ROSSOR MN. Management of neurological disorders : dementia. J Neurol Neurosurg Psychiatry 1994 ; 57 : 1451-6.
36. COUGHLAN AK, HOLLOWS SE. The use of memory tests in differentiating organic disorder from depression. Br J Psychol 1984 ; 145 : 164-7.
37. WECKOWICZ TE, NUTTER RW, CRUISE DG. Speed in test performance in relation to depressive illness and age. J Can Psychiatric Assoc 1972 ; 17 (2 suppl.) : 2SS, 241-50.
38. AUSTIN MP, ROSS M, MURRAY S et al. Cognitive function in major depression. J Affect Disord 1992 ; 25 : 21-30.
39. MILLER E, LEWIS P. Recognition memory in elderly patients with depression and dementia : a signal detection analysis. J Abnorm Psychol 1977; 86(1): 84-6.
40. HEATON RK, BAADE LE, JOHNSON KL. Neuropsychological test results associated with psychiatric disorders in adults. Psychol Bull 1978 ; 85 : 141-62.
41. CLARE L, MCKENNA PJ, MORTIMER AM et al. Memory in schizophrenia : what is impaired and what is preserved ? Neuropsychologia 1993 ; 31 : 1225-41.
42. NAGUIB M, LEVY R. Late paraphrenia : neuropsychological impairment and structural brain abnormalities on computed tomography, Int J Geriatr Psychiatry 1987 ; 2 : 83-90.
43. MILLER BL, LESSER IM, BOONE KB et al. Brain lesions and cognitive function in late life psychosis. Br J Psychiatry 1991 ; 158 : 76-82.
44. WILLIAMS JMG, WATTS FN, MACLEOD C et al. Cognitive Psychology and Emotional Disorders. Wiley : Chester, 1988.
45. CHANNON S, BAKER J, ROBERTSON MM. Working memory in clinical depression : an experimental study. Psychol Med 1993 ; 23 : 87-91.
46. GOLDMAN-RAKIC PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994 ; 6 : 348-57.
47. CHEN EYT, LAM LCW, CHEN RYL et al. Prefrontal neuropsychological impairment and illness duration in schizophrenia : a study of 204 patients in Hong Kong. Acta Psychiatr Scand 1996 ; 93 : 144-50.
48. FUSTER J, ALEXANDER G. Neuron activity related to short-term memory. Science 1971 ; 173 : 652-4.
49. BROZOSKI T, BROWN R, ROSVOLD H et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979 ; 205 : 929-31.
50. ARNSTEN K, CAI J, MURPHY B et al, Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 1994 ; 116 : 143-51.
51. LEZAK MD. Neuropsychology Assessment. New York : Oxford University Press, 1983.
52. LORING DW, MARTIN RC, MEADOR KJ. Psychometric construction of the Rey Osterrieth complex figure : Methodological considerations and interrater reliability. Arch Clin Neuropsychol 1990 ; 5: 1-14.
53. WECHSLER DA. Wechsler memory scale revised. New York : Psychological Corporation, 1987.
54. WECHSLER DA. Wechsler Adult Intelligence Scale. New York : Manual Psychological Corporation, 1955.
55. WECHSLER DA. Wechsler Adult Intelligence scale-Revised. New York : Manual Psychological Corporation, 1981.
56. SNAITH RP, CONSTANTOPOULOS AA, JARDINE MY et al. A clinical scale for the self-assessment of irritability. Br J Psychiatry 1978 ; 132 : 164-71.
57. MOREAUD O, NAEGELE B, CHABANNES JP et al. Frontal lobe dysfunction and depressive state : relation to endogenous character of depression. Encephale 1996 ; 22 (1) : 47-51.
58. MEYER UA, AMREIN R, BALANT LP et al. Antidepressants and drug-metabolizing enzymes - expert group report. Acta Psychiatr Scand 1996 ; 93 : 71-9.
59. WIDLOCHER D. Le Ralentissement Dépressif. Paris : Presses Universitaires de France, 1983.
60. MARDER SR, ASARNOW RF, VAN PUTTEN T. Information processing and neuroleptic response in acute and stabilized schizophrenic patients. Psychiatry Res 1984 ; 13 : 41-9.
61. McKINLAY WW. Assessment of the head-injured for compensation, In : Crawford JR, Parker DM, McKinlay WW. eds. A handbook of neuropsychological assessment. Hove, UK : Erlbaum, 1992 : 381-92.
62. MILLER H. Mental after effects of head injury. Proceedings of the Royal Society of Medicine 1966 ; 59 : 257-70.
63. REY A. L'examen clinique en psychologie. Paris : Presses Universitaires de France, 1964.
64. OSTERRIETH PA. Le test de copie d'une figure complexe. Arch Psychol 1944 ; 30 : 206-356.
65. WECHSLER DA. A standardized memory scale for clinical use. J Psychol 1945; 19 : 87-95.
66. HATHAWAY SR, MCKINLEY JC. Booklet for the Minnesota Multiptiasic Personality Inventory. New York : Psychological Corporation, 1943.
67. EYSENCK HJ, EYSENCK BG. Manual for the Eysenck Personality Inventory, Educational and Industrial Testing service. San Diego : California, 1968.
68. RAVEN JC. Standard progressive matrices. London : HK Lewis, 1938.
69. SPREEN O, STRAUSS E. A compendium of neuropsychological tests. Administration, norms and commentary. Oxford : University Press, 1991.
70. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC : American Psychiatric Association Press, 1987.
71. CLAYTON PJ. The comorbidity factor : establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990 ; 51 (11 suppl.) : 35-9.
72. PAUL SM. Anxiety and depression : a common neurobiological substrate ? J Clin Psychiatry 1988 ; 49 (10 suppl.) : 13-6.
73. CORYELL W, ENDICOTT J, WINOKUR G. Anxiety syndromes as epiphenomena of primary major depression : outcome and familial psychopathotogy. Am J Psychiatry 1992 ; 149 (1) : 100-7.
74. CLAYTON PJ, GROVE WM, CORYELL W et al. Follow up and family study of anxious depression. Am J Psychiatry 1991 ; 148 : 1512-7.
75. BARLOW D, DI NORDO P, VERMILYEA B. Co-morbidity and depression among the anxiety disorders : issues on diagnosis and clarification. J Nerv Ment Dis 1986 ; 174 : 63-72.
76. LADER MH, Marks IM. Clinical anxiety. London : Heinneman Medical, 1971.
77. FAWCETT J, KRAVITZ HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983 ; 44 (8) : 8-11.
78. LECKMAN J, MERIKANGAS K, PAULS DL et al. Anxiety disorders and depression : contradictions between family study data and DSM III convention. Am J Psychiatry 1983 ; 140 : 880-2.
79. MAIER W, BULLER R, PHILLIP M et al. The Hamilton Anxiety Scale : reliability, validity, and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988 ; 14 : 61-8.
80. BECH P. Rating scales for mood disorders : applicability, consistency and construct validity. Acta Psychiatr Scand 1988 ; 78 (suppl. 345) : 45-55.
81. KILOH LG. Pseudo-dementia. Acta Psychiatr Scand 1961 ; 37 : 336-51.
82. WEINGARTNER H, COHEN RM, MURPHY DL et al. Cognitive processes in depression. Arch Gen Psychiatry 1981 ; 38 : 42-7.
83. GOLOMBOK S, MOODLEY P, LADER M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988 ; 18 : 365-74.
84. DEAKIN JFW. 5HT2 receptors, depression and anxiety. Pharm Biochemistry Behav 1988 ; 29 : 819-20.
85. nd edition. New York : Raven Press, 1986 : 223-39.
86. AZORIN JM. Prise en charge des somatisations dépressives. Encephale 1995 ; Sp.VII : 17-22.
87. RABIN D, GOLD PW, MARGIORIS A et al. Stress and reproduction. In : Chrousos GP, Loiaux KL, Gold PW, ed. Physical and emotional stress : biochemical mechanisms and clinical implications. (Advances in experimental medicine and biology). New York : Plenum Press, 1988 : 377-87.
88. BARBARINO A, DE MARINIS L, TOFANI A et al. Corticotrophin releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J Clin Endocrinol Metab 1989 ; 68 : 523-8.
89. PETRAGLIA F, SUTTON S, VALE W et al. Corticotropin releasing factor decreases plasma LH levels in female rats by inhibiting gonadotropin releasing hormone release into hypophyseal portal circulation. Endocrinology 1987 ; 120 : 1083-8.
90. SQUIRE LR. Memory and brain. New York : Oxford University Press, 1987.